Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor–Induced Thyroiditis

AACE Clinical Case Reports(2023)10.1016/j.aace.2023.05.009Source: DataRank Database

Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor–Induced Thyroiditis is a research paper published in AACE Clinical Case Reports (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.34)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Heinz‐Josef Lenz ORCID,Melissa G. Lechner ORCID,Trevor E. Angell ORCID,Dennis H. Chen ORCID

Live enrichment

PubMed:37736314 PMC:PMC10509378 OpenAlex:https://openalex.org/W4379259104

National Institutes of Health

Grant: K08DK129829

National Institutes of Health

Grant: 5K08DK129829-03

Mechanisms of Thyroid Autoimmunity in Checkpoint Immunotherapy

FWCI

0.34

Citation Percentile

0.6%

Citation Trend

2023

2026

goldLicense: cc-by-nc-nd

journalhttp://www.aaceclinicalcasereports.com/article/S2376060523001153/pdf

publisherhttp://www.aaceclinicalcasereports.com/article/S2376060523001153/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2376060523001153?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2376060523001153?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.aace.2023.05.009

Fields of Study

Cancer Immunotherapy and BiomarkersThyroid Cancer Diagnosis and TreatmentMultiple and Secondary Primary Cancers03 medical and health sciences0302 clinical medicine

Keywords

MedicineThyroiditisPapillary thyroid cancerLevothyroxineThyroid cancerInternal medicineThyroidThyroid carcinomaGastroenterologyColorectal cancerImmune systemMalignancyAdverse effectOncologyCancerImmunologyefficacyPapillary Thyroid CarcinomaImmune-related Adverse EventsImmune Checkpoint InhibitorsCase ReportRC648-665Diseases of the endocrine glands. Clinical endocrinology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being